Cargando…
The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer
The CRISPR-Cas system was identified in bacteria as an immune defense mechanism against threats from the external environment. A common form of this system, called CRISPR-Cas9, is now widely used in gene editing, especially in mammalian cells. Through CRISPR-Cas9, gene knock-ins or knock-outs have b...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086466/ https://www.ncbi.nlm.nih.gov/pubmed/35548117 http://dx.doi.org/10.1039/c8ra04509g |
_version_ | 1784704007333216256 |
---|---|
author | Zhang, Jiayu Zhou, Wenlong Wang, Xiaoxuan Wang, Lihui |
author_facet | Zhang, Jiayu Zhou, Wenlong Wang, Xiaoxuan Wang, Lihui |
author_sort | Zhang, Jiayu |
collection | PubMed |
description | The CRISPR-Cas system was identified in bacteria as an immune defense mechanism against threats from the external environment. A common form of this system, called CRISPR-Cas9, is now widely used in gene editing, especially in mammalian cells. Through CRISPR-Cas9, gene knock-ins or knock-outs have become more feasible, thus deepening our understanding of the mechanisms of human diseases, including cancers, and suggesting possible treatment strategies. In this review, we discuss how CRISPR-Cas9 can be used as a tool to discover more about drug-resistance in cancers, including both the underlying mechanisms and ways to overcome them. |
format | Online Article Text |
id | pubmed-9086466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-90864662022-05-10 The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer Zhang, Jiayu Zhou, Wenlong Wang, Xiaoxuan Wang, Lihui RSC Adv Chemistry The CRISPR-Cas system was identified in bacteria as an immune defense mechanism against threats from the external environment. A common form of this system, called CRISPR-Cas9, is now widely used in gene editing, especially in mammalian cells. Through CRISPR-Cas9, gene knock-ins or knock-outs have become more feasible, thus deepening our understanding of the mechanisms of human diseases, including cancers, and suggesting possible treatment strategies. In this review, we discuss how CRISPR-Cas9 can be used as a tool to discover more about drug-resistance in cancers, including both the underlying mechanisms and ways to overcome them. The Royal Society of Chemistry 2018-09-28 /pmc/articles/PMC9086466/ /pubmed/35548117 http://dx.doi.org/10.1039/c8ra04509g Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Zhang, Jiayu Zhou, Wenlong Wang, Xiaoxuan Wang, Lihui The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer |
title | The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer |
title_full | The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer |
title_fullStr | The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer |
title_full_unstemmed | The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer |
title_short | The CRISPR-Cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer |
title_sort | crispr-cas9 system: a promising tool for discovering potential approaches to overcome drug resistance in cancer |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086466/ https://www.ncbi.nlm.nih.gov/pubmed/35548117 http://dx.doi.org/10.1039/c8ra04509g |
work_keys_str_mv | AT zhangjiayu thecrisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer AT zhouwenlong thecrisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer AT wangxiaoxuan thecrisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer AT wanglihui thecrisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer AT zhangjiayu crisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer AT zhouwenlong crisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer AT wangxiaoxuan crisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer AT wanglihui crisprcas9systemapromisingtoolfordiscoveringpotentialapproachestoovercomedrugresistanceincancer |